Serum Erythropoietin as Prognostic Marker in Myelodysplastic Syndromes

Introduction: This myelodysplastic syndromes are a heterogeneous entity characterized by dysplasia, hypercellular bone marrow, cytopenias and risk of transformation to acute leukaemia. Prognostic factors, such as bone marrow fibrosis, lactate dehydrogenase and β2-microglobulin elevation have been de...

Full description

Bibliographic Details
Main Author: Cortesão, Emília (author)
Other Authors: Tenreiro, Rita (author), Ramos, Sofia (author), Pereira, Marta (author), César, Paula (author), Carda, José P. (author), Gomes, Marília (author), Rito, Luís (author), Magalhães, Emília (author), Gonçalves, Ana C. (author), Silva, Nuno C. e (author), Geraldes, Catarina (author), Pereira, Amélia (author), Ribeiro, Letícia (author), Nascimento Costa, José M. (author), Ribeiro, Ana B. Sarmento (author)
Format: article
Language:por
eng
Published: 2015
Subjects:
Erythropoietin
Myelodysplastic Syndromes
Prognosis.
Eritropoietina
Prognóstico
Síndrome Mielodisplásica.
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6518
Country:Portugal
Oai:oai:ojs.www.actamedicaportuguesa.com:article/6518

Internet

https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6518

Similar Items